Canadian clinical practice guidelines for acute and chronic rhinosinusitis

Allergy, Asthma and Clinical Immunology

Volumn 7, Issue 1, 2011, Pages

  Desrosiers, Martin ^a   Evans, Gerald A ^b   Keith, Paul K ^c   Wright, Erin D ^d   Kaplan, Alan ^e   Bouchard, Jacques ^f   Ciavarella, Anthony ^g   Doyle, Patrick W ^h   Javer, Amin R ⁱ   Leith, Eric S ^j   Mukherji, Atreyi ^c   Schellenberg, R Robert ⁱ   Small, Peter ^k   Witterick, Ian J ^l  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e University of Queensland   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g Family Physician Airways Group of Canada   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j WOMEN S COLLEGE HOSPITAL   (Canada)

^k MCGILL UNIVERSITY   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BROMELAIN; BUDESONIDE; CEFACLOR; CINEOLE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DRISTAN; ECHINACEA EXTRACT; ERYTHROMYCIN; ESBERITOX; GATIFLOXACIN; GEMIFLOXACIN; GUAIFENESIN; LEVOFLOXACIN; MOMETASONE FUROATE; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE; ROXITHROMYCIN; SINUPRET; UNINDEXED DRUG; XYLOMETAZOLINE;

ACUTE RHINOSINUSITIS; ALLERGY; ALTERNATIVE MEDICINE; ANOSMIA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL SINUSITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CANADA; CHRONIC RHINOSINUSITIS; CLINICAL EFFECTIVENESS; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; COUGHING; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ETHMOID BONE; FACE PAIN; FATIGUE; GASTROESOPHAGEAL REFLUX; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HALITOSIS; HEADACHE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HYPOSMIA; INDWELLING CATHETER; INFECTION CONTROL; INTERNAL AUDITORY CANAL; MAXILLA; MAXILLA SINUSITIS; MEDICAL EDUCATION; MONOTHERAPY; MORAXELLA CATARRHALIS; MUCOCILIARY CLEARANCE; NASAL LAVAGE; NOSE CAVITY; NOSE OBSTRUCTION; NOSE SECRETION; NOSE SMEAR; OTALGIA; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSEUDOMONAS AERUGINOSA; PUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SKIN TEST; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURGICAL DRAINAGE; TH1 CELL; TH2 CELL; TOOTH PAIN; TREATMENT RESPONSE; TURBINATE; UPPER RESPIRATORY TRACT; VACCINATION;

EID: 80051616626     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-7-2     Document Type: Review

References (240)

1. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004, 193:3-5.
2. Macdonald KI, McNally JD, Massoud E. The health and resource utilization of Canadians with chronic rhinosinusitis. Laryngoscope 2009, 119:184-189. 10.1002/lary.20034, 19117310.
3. IMS Health Canadian Disease and Therapeutic Index (CDTI) database. 2006, IMS Health.
4. Pleis J, Lucas J. Summary health statistics for U.S. adults: National Health Interview Survey, 2007. National Center for Health Statistics. Vital Health Stat 2009, 10.
5. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996, 23:1209-1223. quiz 1224-1205.
6. Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003, 113:1199-1205. 10.1097/00005537-200307000-00016, 12838019.
7. Classifying recommendations for clinical practice guidelines. Pediatrics 2004, 114:874-877. 10.1542/peds.2004-1260, 15342869.
8. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006, 174:605-614. 10.1164/rccm.200602-197ST, 16931644.
9. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC, Hudgins PA, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007, 137:S1-31. 10.1016/j.otohns.2007.06.726, 17761281.
10. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003, 139:843-857.
11. Appraisal of guidelines for research and evaluation (AGREE) instrument. , http://www.agreecollaboration.org/instrument/
12. Gwaltney JM. Rhinovirus infection of the normal human airway. Am J Respir Crit Care Med 1995, 152:S36-39.
13. Gwaltney JM. Viral respiratory infection therapy: historical perspectives and current trials. Am J Med 2002, 112(Suppl 6A):33S-41S. 10.1016/S0002-9343(01)01062-2, 11955458.
14. Gwaltney JM, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994, 330:25-30. 10.1056/NEJM199401063300105, 8259141.
15. Infectious rhinosinusitis in adults: classification, etiology and management. International Rhinosinusitis Advisory Board. Ear Nose Throat J 1997, 76:1-22.
16. Desrosiers M, Frenkiel S, Hamid QA, Low D, Small P, Carr S, Hawke M, Kirkpatrick D, Lavigne F, Mandell L, et al. Acute bacterial sinusitis in adults: management in the primary care setting. J Otolaryngol 2002, 31(Suppl 2):2S2-14.
17. Piccirillo JF. Clinical practice. Acute bacterial sinusitis. N Engl J Med 2004, 351:902-910. 10.1056/NEJMcp035553, 15329428.
18. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997, 117:S1-7. 10.1016/S0194-5998(97)70001-9, 9334782.
19. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007, 1-136.
20. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Emerg Med 2001, 37:703-710. 10.1067/S0196-0644(01)70089-3, 11385344.
21. Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, Dixon TA, Huber PA, Nasser SM. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008, 38:260-275. 10.1111/j.1365-2222.2007.02889.x, 18167126.
22. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Sinus and Allergy Health Partnership. Otolaryngol Head Neck Surg 2000, 123:5-31. 10.1067/mhn.2000.107873, 10887346.
23. Evans FO, Sydnor JB, Moore WE, Moore GR, Manwaring JL, Brill AH, Jackson RT, Hanna S, Skaar JS, Holdeman LV, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975, 293:735-739. 10.1056/NEJM197510092931502, 169466.
24. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988, 105:343-349. 10.3109/00016488809097017, 3389120.
25. Williams JW, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992, 117:705-710.
26. Hadley JA, Schaefer SD. Clinical evaluation of rhinosinusitis: history and physical examination. Otolaryngol Head Neck Surg 1997, 117:S8-11. 10.1016/S0194-5998(97)70002-0, 9334783.
27. Low DE, Desrosiers M, McSherry J, Garber G, Williams JW, Remy H, Fenton RS, Forte V, Balter M, Rotstein C, et al. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ 1997, 156(Suppl 6):S1-14.
28. Blomgren K, Hytonen M, Pellinen J, Relander M, Pitkaranta A. Diagnostic accuracy of acute maxillary sinusitis in adults in primary care. Scand J Prim Health Care 2002, 20:40-44. 10.1080/028134302317282734, 12086283.
29. Thomas C, Aizin V. Brief report: a red streak in the lateral recess of the oropharynx predicts acute sinusitis. J Gen Intern Med 2006, 21:986-988. 10.1007/BF02743149, 1831603, 16918746.
30. Young J, Bucher H, Tschudi P, Periat P, Hugenschmidt C, Welge-Lussen A. The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences. J Clin Epidemiol 2003, 56:377-384. 10.1016/S0895-4356(02)00590-5, 12767415.
31. Ashraf N, Bhattacharyya N. Determination of the "incidental" Lund score for the staging of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2001, 125:483-486.
32. Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope 1991, 101:56-64. 10.1288/00005537-199101000-00010, 1984551.
33. Flinn J, Chapman ME, Wightman AJ, Maran AG. A prospective analysis of incidental paranasal sinus abnormalities on CT head scans. Clin Otolaryngol Allied Sci 1994, 19:287-289. 10.1111/j.1365-2273.1994.tb01232.x, 7994882.
34. Gamble R. Acute inflammations of the orbit in children. Arch Ophthalmol 1933, 10:483-497.
35. Patt BS, Manning SC. Blindness resulting from orbital complications of sinusitis. Otolaryngol Head Neck Surg 1991, 104:789-795.
36. Gungor A, Corey JP. Pediatric sinusitis: a literature review with emphasis on the role of allergy. Otolaryngol Head Neck Surg 1997, 116:4-15. 10.1016/S0194-5998(97)70344-9, 9018250.
37. Kuranov NI. [Orbital and intracranial complications of rhinosinusitis]. Vestn Otorinolaringol 2001, 46-47.
38. Eustis HS, Mafee MF, Walton C, Mondonca J. MR imaging and CT of orbital infections and complications in acute rhinosinusitis. Radiol Clin North Am 1998, 36:1165-1183. xi, 10.1016/S0033-8389(05)70238-4, 9884695.
39. Rumelt S, Rubin PA. Potential sources for orbital cellulitis. Int Ophthalmol Clin 1996, 36:207-221. 10.1097/00004397-199603630-00019, 8989612.
40. Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope 1998, 108:1635-1642. 10.1097/00005537-199811000-00009, 9818818.
41. Broberg T, Murr A, Fischbein N. Devastating complications of acute pediatric bacterial sinusitis. Otolaryngol Head Neck Surg 1999, 120:575-579. 10.1053/hn.1999.v120.a84893, 10187964.
42. Giannoni CM, Stewart MG, Alford EL. Intracranial complications of sinusitis. Laryngoscope 1997, 107:863-867. 10.1097/00005537-199707000-00005, 9217120.
43. Axelsson A, Brorson JE. The correlation between bacteriological findings in the nose and maxillary sinus in acute maxillary sinusitis. Laryngoscope 1973, 83:2003-2011. 10.1288/00005537-197312000-00011, 4149238.
44. Gwaltney JM, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992, 90:457-461. discussion 462, 10.1016/0091-6749(92)90169-3, 1527337.
45. Gwaltney JM, Sydnor A, Sande MA. Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl 1981, 90:68-71.
46. Van Cauwenberge P, Verschraegen G, Van Renterghem L. Bacteriological findings in sinusitis (1963-1975). Scand J Infect Dis Suppl 1976, 72-77.
47. Joniau S, Vlaminck S, Van Landuyt H, Kuhweide R, Dick C. Microbiology of sinus puncture versus middle meatal aspiration in acute bacterial maxillary sinusitis. Am J Rhinol 2005, 19:135-140.
48. Talbot GH, Kennedy DW, Scheld WM, Granito K. Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis. Clin Infect Dis 2001, 33:1668-1675. 10.1086/323813, 11595989.
49. Vogan JC, Bolger WE, Keyes AS. Endoscopically guided sinonasal cultures: a direct comparison with maxillary sinus aspirate cultures. Otolaryngol Head Neck Surg 2000, 122:370-373. 10.1016/S0194-5998(00)70051-9, 10699813.
50. Benninger MS, Payne SC, Ferguson BJ, Hadley JA, Ahmad N. Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg 2006, 134:3-9. 10.1016/j.otohns.2005.10.010, 16399172.
51. Sande MA, Gwaltney JM. Acute community-acquired bacterial sinusitis: continuing challenges and current management. Clin Infect Dis 2004, 39(Suppl 3):S151-158. 10.1086/421353, 15546110.
52. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med 2001, 111(Suppl 9A):19S-24S. 10.1016/S0002-9343(01)01027-0, 11755439.
53. Brook I. Bacteriology of acute and chronic ethmoid sinusitis. J Clin Microbiol 2005, 43:3479-3480. 10.1128/JCM.43.7.3479-3480.2005, 1169095, 16000483.
54. Jousimies-Somer HR, Savolainen S, Ylikoski JS. Bacteriological findings of acute maxillary sinusitis in young adults. J Clin Microbiol 1988, 26:1919-1925. 266792, 3182986.
55. Wald ER. Microbiology of acute and chronic sinusitis in children. J Allergy Clin Immunol 1992, 90:452-456. 10.1016/0091-6749(92)90168-2, 1527336.
56. Benninger M, Brook I, Farrell DJ. Disease severity in acute bacterial rhinosinusitis is greater in patients infected with Streptococcus pneumoniae than in those infected with Haemophilus influenzae. Otolaryngol Head Neck Surg 2006, 135:523-528. 10.1016/j.otohns.2006.06.1247, 17011411.
57. Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol 2006, 55:943-946. 10.1099/jmm.0.46346-0, 16772423.
58. Green K, Pong-Porter S, et al. Trends in antimicrobial prescribing and pneumococcal resistance, Canada, 1993-2005. 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco 2006,
59. Green K, McGreer A, et al. Trends in antimicrobial resistance in Canadian strains of Streptococcus pneumoniae, 1988-2003. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago 2003,
60. Percentage of penicillin non-susceptible S. pneumoniae in Canada: 1988-2007. , http://microbiology.mtsinai.on.ca/data/sp/sp_2007.shtml#figure1
61. de Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelingen JC. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997, 50:881-890. 10.1016/S0895-4356(97)00117-0, 9291872.
62. Marple BF, Brunton S, Ferguson BJ. Acute bacterial rhinosinusitis: a review of U.S. treatment guidelines. Otolaryngol Head Neck Surg 2006, 135:341-348. 10.1016/j.otohns.2005.12.021, 16949962.
63. Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003, 47:1875-1881. 10.1128/AAC.47.6.1875-1881.2003, 155833, 12760861.
64. Huang WH, Hung PK. Methicillin-resistant Staphylococcus aureus infections in acute rhinosinusitis. Laryngoscope 2006, 116:288-291. 10.1097/01.mlg.0000197316.36698.c4, 16467721.
65. Barton M, Hawkes M, Moore D, Conly J, Nicolle L, Allen U, Boyd N, Embree J, Horne LV, Saux NL, et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 2006, 17(suppl C):4C-24C.
66. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879.
67. Osguthorpe JD. Adult rhinosinusitis: diagnosis and management. Am Fam Physician 2001, 63:69-76.
68. de Ferranti SD, Ioannidis JP, Lau J, Anninger WV, Barza M. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998, 317:632-637. 28657, 9727991.
69. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW, Makela M. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2009, CD000243.
70. Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis 2008, 8:543-552. 10.1016/S1473-3099(08)70202-0, 18718440.
71. Scheid DC, Hamm RM. Acute bacterial rhinosinusitis in adults: part II. Treatment. Am Fam Physician 2004, 70:1697-1704.
72. Young J, De Sutter A, Merenstein D, van Essen GA, Kaiser L, Varonen H, Williamson I, Bucher HC. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008, 371:908-914. 10.1016/S0140-6736(08)60416-X, 18342685.
73. Lindbaek M, Butler CC. Antibiotics for sinusitis-like symptoms in primary care. Lancet 2008, 371:874-876. 10.1016/S0140-6736(08)60390-6, 18342666.
74. Rosenfeld RM, Singer M, Jones S. Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngol Head Neck Surg 2007, 137:S32-45. 10.1016/j.otohns.2007.06.724, 17761282.
75. Hadley JA, Mosges R, Desrosiers M, Haverstock D, van Veenhuyzen D, Herman-Gnjidic Z. Moxifloxacin five-day therapy vs. placebo in acute bacterial sinusitis. The Laryngoscope 2010, 120:1057-1062.
76. Adelglass J, DeAbate CA, McElvaine P, Fowler CL, LoCocco J, Campbell T. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surg 1999, 120:320-327. 10.1016/S0194-5998(99)70269-X, 10064632.
77. Arrieta JR, Galgano AS, Sakano E, Fonseca X, Amabile-Cuevas CF, Hernandez-Oliva G, Vivar R, Gonzalez G, Torres A. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolaryngol 2007, 28:78-82. 10.1016/j.amjoto.2006.06.016, 17362810.
78. Buchanan P, Roos K, Tellier G, Rangaraju M, Leroy B. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis. Int J Antimicrob Agents 2005, 25:237-246. 10.1016/j.ijantimicag.2004.12.002, 15737519.
79. Bucher HC, Tschudi P, Young J, Periat P, Welge-Luussen A, Zust H, Schindler C. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Arch Intern Med 2003, 163:1793-1798. 10.1001/archinte.163.15.1793, 12912714.
80. Burke T, Villanueva C, Mariano H, Huck W, Orchard D, Haverstock D, Heyd A, Church D. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. Clin Ther 1999, 21:1664-1677. 10.1016/S0149-2918(99)80046-0, 10566563.
81. Ferguson BJ, Guzzetta RV, Spector SL, Hadley JA. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004, 131:207-214. 10.1016/j.otohns.2004.05.010, 15365537.
82. Henry DC, Kapral D, Busman TA, Paris MM. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. Clin Ther 2004, 26:2026-2033. 10.1016/j.clinthera.2004.12.004, 15823766.
83. Lasko B, Lau CY, Saint-Pierre C, Reddington JL, Martel A, Anstey RJ. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. J Int Med Res 1998, 26:281-291.
84. Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjoback D, Ibanez JM, Hampel B, Sommerauer B. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med 2000, 94:337-344. 10.1053/rmed.1999.0769, 10845431.
85. Upchurch J, Rosemore M, Tosiello R, Kowalsky S, Echols R. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg 2006, 135:511-517. 10.1016/j.otohns.2006.05.034, 17011409.
86. Canadian Pharmacists Association Compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals 2007, Ottawa: Canadian Pharmacists Association, Canadian Pharmacists Association.
87. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 2000, 9:722-726. 10.1001/archfami.9.8.722, 10927711.
88. Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 2004, 117(Suppl 3A):3S-15S.
89. Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999, 103:E28. 10.1542/peds.103.3.e28, 10049984.
90. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005, 40:1288-1297. 10.1086/429242, 15825031.
91. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006, 43:432-438. 10.1086/505871, 16838231.
92. Fuller JD, McGeer A, Low DE. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management. Eur J Clin Microbiol Infect Dis 2005, 24:780-788. 10.1007/s10096-005-0059-x, 16344922.
93. Low D. Managing antibiotic resistance. Canadian Bacterial Surveillance Network Newsletter 2005,
94. Gwaltney JM, Wiesinger BA, Patrie JT. Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history. Clin Infect Dis 2004, 38:227-233. 10.1086/380641, 14699455.
95. Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. Otolaryngol Head Neck Surg 2005, 133:194-200. 10.1016/j.otohns.2005.04.020, 16087013.
96. Henry DC, Riffer E, Sokol WN, Chaudry NI, Swanson RN. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother 2003, 47:2770-2774. 10.1128/AAC.47.9.2770-2774.2003, 182642, 12936972.
97. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, Lau J. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother 2001, 48:677-689. 10.1093/jac/48.5.677, 11679557.
98. Poole M, Anon J, Paglia M, Xiang J, Khashab M, Kahn J. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg 2006, 134:10-17. 10.1016/j.otohns.2005.11.026, 16399173.
99. Sher LD, McAdoo MA, Bettis RB, Turner MA, Li NF, Pierce PF. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Clin Ther 2002, 24:269-281. 10.1016/S0149-2918(02)85023-8, 11911557.
100. Ferguson BJ, Anon J, Poole MD, Hendrick K, Gilson M, Seltzer EG. Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin. Otolaryngol Head Neck Surg 2002, 127:1-6. 10.1067/mhn.2002.126593, 12161723.
101. Seggev JS, Enrique RR, Brandon ML, Larsen LS, Van Tuyl RA, Rowinski CA. A combination of amoxicillin and clavulanate every 12 hours vs every 8 hours for treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1998, 124:921-925.
102. Riffer E, Spiller J, Palmer R, Shortridge V, Busman TA, Valdes J. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study. Curr Med Res Opin 2005, 21:61-70. 10.1185/030079904X18009, 15881476.
103. Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, Dresser L, Low DE, Mamdani MM. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006, 354:1352-1361. 10.1056/NEJMoa055191, 16510739.
104. Ip S, Fu L, Balk E, Chew P, Devine D, Lau J. Update on acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) 2005, 1-3.
105. Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev 2007, CD005149.
106. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 2001, 286:3097-3105. 10.1001/jama.286.24.3097, 11754675.
107. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005, 116:1289-1295. 10.1016/j.jaci.2005.08.044, 16337461.
108. Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology 2007, 45:190-196.
109. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, Little P. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA 2007, 298:2487-2496. 10.1001/jama.298.21.2487, 18056902.
110. Meltzer EO. Antibiotics and nasal steroids for acute sinusitis. JAMA 2008, 299:1422-1423. author reply 1423, 10.1001/jama.299.12.1422-b, 18364480.
111. Ambrose PG, Anon JB, Owen JS, Van Wart S, McPhee ME, Bhavnani SM, Piedmonte M, Jones RN. Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis. Clin Infect Dis 2004, 38:1513-1520. 10.1086/420739, 15156435.
112. Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis 2008, 61:13-20. 10.1016/j.diagmicrobio.2008.01.010, 18313879.
113. Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN, Kahn JB. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis 2007, 57:105-107. 10.1016/j.diagmicrobio.2006.10.019, 17178300.
114. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997, 78:598-601. 10.1016/S1081-1206(10)63223-1, 9207726.
115. Nayak AS, Settipane GA, Pedinoff A, Charous BL, Meltzer EO, Busse WW, Zinreich SJ, Lorber RR, Rikken G, Danzig MR. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002, 89:271-278. 10.1016/S1081-1206(10)61954-0, 12269647.
116. Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope 1992, 102:1225-1228. 10.1288/00005537-199211000-00004, 1357516.
117. Sisson JH, Yonkers AJ, Waldman RH. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers. Chest 1995, 107:747-751. 10.1378/chest.107.3.747, 7874947.
118. Inanli S, Ozturk O, Korkmaz M, Tutkun A, Batman C. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope 2002, 112:320-325. 10.1097/00005537-200202000-00022, 11889391.
119. Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract 2002, 51:1049-1055.
120. Keojampa BK, Nguyen MH, Ryan MW. Effects of buffered saline solution on nasal mucociliary clearance and nasal airway patency. Otolaryngol Head Neck Surg 2004, 131:679-682. 10.1016/j.otohns.2004.05.026, 15523448.
121. Hauptman G, Ryan MW. The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients. Otolaryngol Head Neck Surg 2007, 137:815-821. 10.1016/j.otohns.2007.07.034, 17967652.
122. Adam P, Stiffman M, Blake RL. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. Arch Fam Med 1998, 7:39-43. 10.1001/archfami.7.1.39, 9443697.
123. Clinical practice guideline: management of sinusitis. Pediatrics 2001, 108:798-808.
124. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999, 48:628-635.
125. Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol Head Neck Surg 2006, 135:496-506. 10.1016/j.otohns.2006.06.1254, 17011407.
126. Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, Heger PW. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial. Explore (NY) 2007, 3:98-109. 10.1016/j.explore.2006.12.007, 17362845.
127. Pittet D, Allegranzi B, Sax H, Dharan S, Pessoa-Silva CL, Donaldson L, Boyce JM. Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis 2006, 6:641-652. 10.1016/S1473-3099(06)70600-4, 17008173.
128. Gutman M, Torres A, Keen KJ, Houser SM. Prevalence of allergy in patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 2004, 130:545-552. 10.1016/j.otohns.2004.02.007, 15138418.
129. Emanuel IA, Shah SB. Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 2000, 123:687-691. 10.1067/mhn.2000.110961, 11112958.
130. Alho OP, Karttunen R, Karttunen TJ. Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Clin Exp Immunol 2004, 137:366-372. 10.1111/j.1365-2249.2004.02530.x, 1809099, 15270854.
131. Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, Lanza DC, Marple BF, Osguthorpe JD, Stankiewicz JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129:S1-32. 10.1016/S0194-5998(03)01397-4, 12958561.
132. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995, 113:104-109. 10.1016/S0194-5998(95)70152-4, 7603703.
133. Small P, Frenkiel S, et al. Rhinitis: A practical and comprehensive approach to assessement and therapy. J Otolaryngol 2007, 36(suppl 1):S5-S28.
134. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-334. 10.1067/mai.2001.118891, 11707753.
135. Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, Jones N, Kalogjera L, Kennedy D, Kowalski M, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005, 60:583-601. 10.1111/j.1398-9995.2005.00830.x, 15813802.
136. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Bachert C, Baraniuk J, Baroody FM, Benninger MS, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004, 114:155-212. 10.1016/j.jaci.2004.09.029, 15577865.
137. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006, 118:S17-61. 10.1016/j.jaci.2006.09.005, 17084217.
138. Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, Wald ER, Khan DA, Blessing-Moore J, Lang DM, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005, 116:S13-47. 10.1016/j.jaci.2005.09.048, 16416688.
139. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006, 116:1121-1126. 10.1097/01.mlg.0000221954.05467.54, 16826045.
140. Foreman A, Singhal D, Psaltis AJ, Wormald PJ. Targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitis. Laryngoscope 2010, 120:427-431. 10.1002/lary.21024, 19950368.
141. Tantilipikorn P, Fritz M, Tanabodee J, Lanza DC, Kennedy DW. A comparison of endoscopic culture techniques for chronic rhinosinusitis. Am J Rhinol 2002, 16:255-260.
142. Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?. Otolaryngol Head Neck Surg 2007, 137:555-561. 10.1016/j.otohns.2007.02.004, 17903570.
143. Bhattacharyya T, Piccirillo J, Wippold FJ. Relationship between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 1997, 123:1189-1192. 2.
144. Bhattacharyya N. Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis. Laryngoscope 2006, 116:1-22. 10.1097/01.mlg.0000224508.59725.19, 16826087.
145. Stewart MG, Sicard MW, Piccirillo JF, Diaz-Marchan PJ. Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms?. Am J Rhinol 1999, 13:161-167. 10.2500/105065899781389704, 10392233.
146. Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Burner H. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005, 35:1186-1191. 10.1111/j.1365-2222.2005.02316.x, 16164446.
147. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006, 61:1280-1289. 10.1111/j.1398-9995.2006.01225.x, 17002703.
148. Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S, et al. Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. Proc Am Thorac Soc 2009, 6:288-294. 10.1513/pats.200808-088RM, 2677404, 19387032.
149. Ramanathan M, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 2008, 22:115-121. 10.2500/ajr.2008.22.3136, 2904676, 18416964.
150. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006, 20:138-144. 2810150, 16686375.
151. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175:3463-3468.
152. Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK, Yasruel Z, Schotman E, Hamid Q. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995, 96:537-544. 10.1016/S0091-6749(95)70298-9, 7560666.
153. Wright ED, Frenkiel S, Al-Ghamdi K, Ghaffar O, Small P, Troutt T, Tavernier J, Hamid Q. Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 1998, 118:490-495.
154. Ghaffar O, Durham SR, Al-Ghamdi K, Wright E, Small P, Frenkiel S, Gould HJ, Hamid Q. Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis. Am J Respir Cell Mol Biol 1998, 18:706-711.
155. Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 1998, 118:504-511. 10.1016/S0194-5998(98)70209-8, 9560103.
156. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003, 113:1803-1812. 10.1097/00005537-200310000-00027, 14520110.
157. Newman LJ, Platts-Mills TA, Phillips CD, Hazen KC, Gross CW. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994, 271:363-367. 10.1001/jama.271.5.363, 8283586.
158. Rolla G, Guida G, Heffler E, Badiu I, Bommarito L, De Stefani A, Usai A, Cosseddu D, Nebiolo F, Bucca C. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest 2007, 131:1345-1352. 10.1378/chest.06-2618, 17317733.
159. Braunstahl GJ, Hellings PW. Nasobronchial interaction mechanisms in allergic airways disease. Curr Opin Otolaryngol Head Neck Surg 2006, 14:176-182. 10.1097/01.moo.0000193186.15440.39, 16728896.
160. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006, 134:991-996. 10.1016/j.otohns.2006.03.001, 16730544.
161. Prince AA, Steiger JD, Khalid AN, Dogrhamji L, Reger C, Eau Claire S, Chiu AG, Kennedy DW, Palmer JN, Cohen NA. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol 2008, 22:239-245. 10.2500/ajr.2008.22.3180, 18588755.
162. Desrosiers M, Hussain A, Frenkiel S, Kilty S, Marsan J, Witterick I, Wright E. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2007, 136:605-609. 10.1016/j.otohns.2006.10.028, 17418259.
163. Conley DB, Tripathi A, Seiberling KA, Suh LA, Harris KE, Paniagua MC, Grammer LC, Kern RC. Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 2006, 20:451-455. 10.2500/ajr.2006.20.2880, 16955778.
164. Seiberling KA, Conley DB, Tripathi A, Grammer LC, Shuh L, Haines GK, Schleimer R, Kern RC. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005, 115:1580-1585. 10.1097/01.mlg.0000168111.11802.9c, 16148698.
165. Zhang N, Holtappels G, Claeys C, Huang G, van Cauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 2006, 20:445-450. 10.2500/ajr.2006.20.2887, 16955777.
166. Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA. Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model. Laryngoscope 2004, 114:887-892. 10.1097/00005537-200405000-00019, 15126750.
167. Plouin-Gaudon I, Clement S, Huggler E, Chaponnier C, Francois P, Lew D, Schrenzel J, Vaudaux P, Lacroix JS. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 2006, 44:249-254.
168. Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004, 66:155-158.
169. Psaltis AJ, Ha KR, Beule AG, Tan LW, Wormald PJ. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 2007, 117:1302-1306. 10.1097/MLG.0b013e31806009b0, 17603329.
170. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005, 115:578-582. 10.1097/01.mlg.0000161346.30752.18, 15805862.
171. Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 2008, 22:1-6. 10.2500/ajr.2008.22.3119, 18284851.
172. Lanza DC, Dhong HJ, Tantilipikorn P, Tanabodee J, Nadel DM, Kennedy DW. Fungus and chronic rhinosinusitis: from bench to clinical understanding. Ann Otol Rhinol Laryngol Suppl 2006, 196:27-34.
173. Sasama J, Sherris DA, Shin SH, Kephart GM, Kern EB, Ponikau JU. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005, 13:2-8. 10.1097/00020840-200502000-00003, 15654207.
174. Van Cauwenberge P, Van Hoecke H, Bachert C. Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep 2006, 6:487-494. 10.1007/s11882-006-0026-3, 17049142.
175. McNally PA, White MV, Kaliner MA. Sinusitis in an allergist's office: analysis of 200 consecutive cases. Allergy Asthma Proc 1997, 18:169-175. 10.2500/108854197778984374, 9194944.
176. Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177-180. 10.1016/S1081-1206(10)62221-1, 11570612.
177. Dibaise JK, Sharma VK. Does gastroesophageal reflux contribute to the development of chronic sinusitis? A review of the evidence. Dis Esophagus 2006, 19:419-424. 10.1111/j.1442-2050.2006.00616.x, 17069583.
178. Weaver EM. Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence. Am J Med 2003, 115(Suppl 3A):81S-89S. 10.1016/S0002-9343(03)00203-1, 12928081.
179. Passali D, Caruso G, Passali FM. ENT manifestations of gastroesophageal reflux. Curr Allergy Asthma Rep 2008, 8:240-244. 10.1007/s11882-008-0040-8, 18589843.
180. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000, 30:481-489. 10.1002/1099-0496(200012)30:6<481::AID-PPUL8>3.0.CO;2-N, 11109061.
181. Wang X, Kim J, McWilliams R, Cutting GR. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 2005, 131:237-240. 10.1001/archotol.131.3.237, 15781764.
182. Sobol SE, Christodoulopoulos P, Manoukian JJ, Hauber HP, Frenkiel S, Desrosiers M, Fukakusa M, Schloss MD, Hamid Q. Cytokine profile of chronic sinusitis in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg 2002, 128:1295-1298.
183. Legent F, Bordure P, Beauvillain C, Berche P. A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994, 40(Suppl 1):8-15. 10.1159/000239310, 7805431.
184. Namyslowski G, Misiolek M, Czecior E, Malafiej E, Orecka B, Namyslowski P, Misiolek H. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother 2002, 14:508-517.
185. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996, 525:73-78.
186. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996, 23:48-56.
187. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004, 114:923-930. 10.1097/00005537-200405000-00027, 15126758.
188. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006, 116:189-193. 10.1097/01.mlg.0000191560.53555.08, 16467702.
189. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001, 125:265-269. 10.1067/mhn.2001.117410, 11555764.
190. Lim M, Citardi MJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol 2008, 22:381-389. 10.2500/ajr.2008.22.3189, 18702902.
191. Videler WJ, van Drunen CM, Reitsma JB, Fokkens WJ. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology 2008, 46:92-98.
192. Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977, 15:17-23.
193. Holopainen E, Grahne B, Malmberg H, Makinien J, Lindqvist N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl 1982, 122:221-228.
194. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975, 5:159-164. 10.1111/j.1365-2222.1975.tb01848.x, 1095246.
195. Filiaci F, Passali D, Puxeddu R, Schrewelius C. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000, 38:185-190.
196. Jankowski R, Schrewelius C, Bonfils P, Saban Y, Gilain L, Prades JM, Strunski V. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 2001, 127:447-452.
197. Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P, Staudinger H, Danzig M. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005, 116:1275-1281. 10.1016/j.jaci.2005.07.027, 16337459.
198. Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2006, 126:606-612. 10.1080/00016480500452566, 16720445.
199. Stjarne P, Mosges R, Jorissen M, Passali D, Bellussi L, Staudinger H, Danzig M. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 2006, 132:179-185. 10.1001/archotol.132.2.179, 16490876.
200. Lund VJ, Black JH, Szabo LZ, Schrewelius C, Akerlund A. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 2004, 42:57-62.
201. Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001, 39:75-79.
202. Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008, 139:340-347. 10.1016/j.otohns.2008.05.628, 18722209.
203. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol Allied Sci 1998, 23:69-73. 10.1046/j.1365-2273.1998.00096.x, 9563670.
204. Alobid I, Benitez P, Pujols L, Maldonado M, Bernal-Sprekelsen M, Morello A, Picado C, Mullol J. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology 2006, 44:8-13.
205. Benitez P, Alobid I, de Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L, Picado C, Mullol J. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 2006, 116:770-775. 10.1097/01.mlg.0000205218.37514.0f, 16652085.
206. Patiar S, Reece P. Oral steroids for nasal polyps. Cochrane Database Syst Rev 2007, CD005232.
207. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007, CD006394.
208. Becker DG. Medical treatment of sinusitis. J Long Term Eff Med Implants 2003, 13:195-205. 10.1615/JLongTermEffMedImplants.v13.i3.60, 14516185.
209. Braun JJ, Alabert JP, Michel FB, Quiniou M, Rat C, Cougnard J, Czarlewski W, Bousquet J. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997, 52:650-655. 10.1111/j.1398-9995.1997.tb01044.x, 9226059.
210. Graf P, Enerdal J, Hallen H. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 1999, 125:1128-1132.
211. Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 2000, 79:18-20. 24-15.
212. Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J 1999, 78:604-606. 608, 613, passim.
213. Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001, 31:1385-1391. 10.1046/j.1365-2222.2001.01160.x, 11591188.
214. Di Rienzo L, Artuso A, Cerqua N. [Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome]. Acta Otorhinolaryngol Ital 2000, 20:336-342.
215. Grundmann T, Topfner M. [Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects]. Laryngorhinootologie 2001, 80:576-582. 10.1055/s-2001-17832, 11602930.
216. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149-1156. 10.1016/j.jaci.2006.07.058, 17088142.
217. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G, Pfister PJ, Tavakkol A. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005, 115:1793-1799. 10.1097/01.mlg.0000175683.81260.26, 16222197.
218. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125-131. 10.1016/j.jaci.2004.09.037, 15637558.
219. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122-1128. 10.1016/j.jaci.2004.03.038, 15208594.
220. Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH, Lin JF, Jiang RS. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol 2008, 22:52-58. 10.2500/ajr.2008.22.3115, 18284860.
221. Jyonouchi H, Sun S, Kelly A, Rimell FL. Effects of exogenous interferon gamma on patients with treatment-resistant chronic rhinosinusitis and dysregulated interferon gamma production: a pilot study. Arch Otolaryngol Head Neck Surg 2003, 129:563-569. 10.1001/archotol.129.5.563, 12759271.
222. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003, 111:180-186. 10.1067/mai.2003.7, 12532116.
223. Dahlen B, Nizankowska E, Szczeklik A, Zetterstrom O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998, 157:1187-1194.
224. Durr DG, Desrosiers M. Evidence-based endoscopic sinus surgery. J Otolaryngol 2003, 32:101-106. 10.2310/7070.2003.37123, 12866594.
225. Smith TL, Mendolia-Loffredo S, Loehrl TA, Sparapani R, Laud PW, Nattinger AB. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2005, 115:2199-2205. 10.1097/01.mlg.0000182825.82910.80, 16369166.
226. Khalil HS, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev 2006, 3:CD004458.
227. Evans KL. Recognition and management of sinusitis. Drugs 1998, 56:59-71. 10.2165/00003495-199856010-00006, 9664199.
228. Smith TL, Batra PS, Seiden AM, Hannley M. Evidence supporting endoscopic sinus surgery in the management of adult chronic rhinosinusitis: a systematic review. Am J Rhinol 2005, 19:537-543.
229. Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope 2008, 118:730-739. 10.1097/MLG.0b013e318161e57b, 18216743.
230. Lavigne F, Cameron L, Renzi PM, Planet JF, Christodoulopoulos P, Lamkioued B, Hamid Q. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002, 112:858-864. 10.1097/00005537-200205000-00015, 12150618.
231. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005, 43:2-10.
232. Dijkstra MD, Ebbens FA, Poublon RM, Fokkens WJ. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy 2004, 34:1395-1400. 10.1111/j.1365-2222.2004.02044.x, 15347372.
233. Jorissen M, Bachert C. Effect of corticosteroids on wound healing after endoscopic sinus surgery. Rhinology 2009, 47:280-286.
234. Stjarne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 2009, 135:296-302. 10.1001/archoto.2009.2, 19289710.
235. Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope 2007, 117:1-28. 10.1097/MLG.0b013e31814842f8, 18075447.
236. Matsuwaki Y, Ookushi T, Asaka D, Mori E, Nakajima T, Yoshida T, Kojima J, Chiba S, Ootori N, Moriyama H. Chronic rhinosinusitis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. Int Arch Allergy Immunol 2008, 146(Suppl 1):77-81. 10.1159/000126066, 18504412.
237. Lane AP, Pine HS, Pillsbury HC. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg 2001, 124:9-15. 10.1067/mhn.2001.111602, 11228445.
238. Chee L, Graham SM, Carothers DG, Ballas ZK. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope 2001, 111:233-235. 10.1097/00005537-200102000-00008, 11210866.
239. Vanlerberghe L, Joniau S, Jorissen M. The prevalence of humoral immunodeficiency in refractory rhinosinusitis: a retrospective analysis. B-ENT 2006, 2:161-166.
240. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg 2000, 126:940-946.